BioMarin Pharmaceutical Inc. (BVMF:B1MR34)

BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 22, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	63,805	77,478	88,130	101,680	90,376	82,667
Market Cap Growth	-17.23%	-12.09%	-13.33%	12.51%	9.32%	35.42%
Enterprise Value	58,982	75,451	87,982	100,715	90,422	82,662
Last Close Price	169.17	203.70	237.12	272.94	257.25	226.00
PE Ratio	23.01	29.35	108.34	135.87	-	18.64
PS Ratio	3.87	4.39	7.51	9.18	8.79	8.56
PB Ratio	1.98	2.21	3.67	4.18	3.80	3.88
P/TBV Ratio	2.13	2.44	4.10	4.73	4.41	4.56
P/FCF Ratio	14.39	25.70	290.28	350.06	77.63	-
P/OCF Ratio	13.10	21.87	114.04	109.34	53.26	186.47
EV/Sales Ratio	3.45	4.28	7.50	9.09	8.79	8.56
EV/EBITDA Ratio	13.22	18.30	62.49	121.62	481.22	1186.81
EV/EBIT Ratio	15.02	21.40	97.60	348.42	-	-
EV/FCF Ratio	13.30	25.03	289.80	346.74	77.67	-
Debt / Equity Ratio	0.10	0.11	0.23	0.24	0.26	0.28
Debt / EBITDA Ratio	0.75	0.93	3.73	6.58	23.56	43.10
Debt / FCF Ratio	0.73	1.30	18.12	20.38	5.38	-
Asset Turnover	0.43	0.41	0.37	0.34	0.31	0.35
Inventory Turnover	0.45	0.50	0.53	0.60	1.49	1.67
Quick Ratio	2.84	2.96	1.45	2.98	2.54	3.07
Current Ratio	4.83	5.33	2.51	4.67	4.16	4.76
Return on Equity (ROE)	9.07%	8.05%	3.51%	3.19%	-1.53%	23.63%
Return on Assets (ROA)	6.15%	5.15%	1.76%	0.55%	-0.78%	-1.09%
Return on Capital (ROIC)	7.01%	5.76%	1.97%	0.61%	-0.87%	-1.24%
Return on Capital Employed (ROCE)	10.40%	8.90%	3.30%	0.90%	-1.40%	-1.70%
Earnings Yield	4.35%	3.41%	0.92%	0.74%	-0.40%	5.37%
FCF Yield	6.95%	3.89%	0.34%	0.29%	1.29%	-0.18%
Buyback Yield / Dilution	-2.10%	-2.67%	-1.39%	-3.34%	4.61%	-7.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.